Irvine, California—Jeffer Mangels Butler & Mitchell LLP is pleased to announce that Joseph J. Mellema has joined the Firm as Of Counsel in the Patent Litigation Group. Mellema will be resident in the Firm’s Orange County office.
Mellema focuses on the protection and enforcement of all intellectual property rights, including patents, trademarks, copyright, trade secrets, unfair business practices, and antitrust litigation. He has dual degrees in electrical engineering and physical sciences, and was formerly a systems engineer at Raytheon Company working on next-generation sensors and systems for the Navy’s F/A-18 Super Hornet.
“Joe has experience litigating highly technical patents in a variety of industries, making him a great addition to our team,” said Stan Gibson, chair of the Patent Litigation Group. “Our patent litigation attorneys have a deep understanding, and often first-hand experience, with the technologies our clients rely on us to protect.”
“JMBM’s efficient and creative approach to patent litigation aligns well with my practice,” said Mellema. “I look forward to working within such a successful group.”
Mellema has particular expertise in the pharmaceutical and medical devices industries, representing companies in patent-related disputes, managing IP portfolios, and conducting due diligence projects. He has also successfully litigated multi-billion dollar complex pharmaceutical cases related to Hatch-Waxman/ANDA litigation.
About JMBM’s Patent Litigation Group
JMBM’s Patent Litigation Group is a team of experienced patent litigators. We represent inventors and entrepreneurs, universities, family-owned businesses, middle-market companies, startups and the FORTUNE 500 in patent litigation. Our patent litigators have tried infringement cases in jurisdictions nationwide. In addition to representing our clients in litigation, we represent them before the United States Patent and Trademark Office (USPTO) in various proceedings including post grant review (PGR), covered business method patents (CBM), and inter partes review (IPR) as well as ex-parte re-examination and supplemental examination proceedings.